多発性硬化症―合併症の治療―（診療ガイドライン2017から）

抄録

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system and combined with various clinical symptoms. The invisible/hidden symptoms of MS, that pain and numbness, fatigue, dysuria, depression, and cognitive dysfunction other than MS motor dysfunction are hard to detect and understand from the outside. Therefore, it is easy to misunderstand at family life and employment. It might be significantly hindrance the patient's quality of life (QOL). In the daily medical care of MS patients, not only the effect of suppressing relapse and/or progression by disease modifying drug, but also understanding the various those complications of the patient and taking appropriate measures will lead to the improvement of QOL by responding to the unmet medical needs of the patient. This paper outlines about the treatment of MS complications based on 「Multiple sclerosis / neuromyelitis optica clinical practice guidelines 2017」.